País: Països Baixos
Idioma: neerlandès
Font: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
LEVOFLOXACINE 0,5-WATER SAMENSTELLING overeenkomend met ; LEVOFLOXACINE
Sandoz B.V. Veluwezoom 22 1327 AH ALMERE
J01MA12
LEVOFLOXACIN 0,5-WATER COMPOSITION corresponding to ; LEVOFLOXACIN
Oplossing voor infusie
NATRIUMCHLORIDE ; WATER VOOR INJECTIE ; ZOUTZUUR (E 507),
Intraveneus gebruik
Levofloxacin
Hulpstoffen: NATRIUMCHLORIDE; WATER VOOR INJECTIE; ZOUTZUUR (E 507);
2009-06-19
Sandoz B.V. Page 1 Levofloxacine Sandoz 5 mg/ml, oplossing voor infusie RVG 101408 V11 1.3.1.3 Bijsluiter December 2019 PACKAGE LEAFLET: INFORMATION FOR THE USER LEVOFLOXACINE SANDOZ ® 5 MG/ML, OPLOSSING VOOR INFUSIE levofloxacin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What [nationally completed name] is and what it is used for 2. What you need to know before you use [nationally completed name] 3. How to use [nationally completed name] 4. Possible side effects 5. How to store [nationally completed name] 6. Contents of the pack and other information 1. WHAT [NATIONALLY COMPLETED NAME] IS AND WHAT IT IS USED FOR The name of your medicine is [nationally completed name]. It contains a medicine called levofloxacin. This belongs to a group of medicines called antibiotics. Levofloxacin is a ‘quinolone’ antibiotic. It works by killing the bacteria that cause infections in your body. [Nationally completed name] can be used to treat infections of the: • Lungs, in people with pneumonia • Urinary tract, including your kidneys or bladder • Prostate gland, where you have a long lasting infection • Skin and underneath the skin, including muscles. This is sometimes called ‘soft tissue’ In some special situations, [Nationally completed name] may be used to lessen the chances of getting a pulmonary disease named anthrax or worsening of the disease after you are exposed to the bacteria causing anthrax. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN [NATIONALLY COMPLETED NAME] DO NOT HAVE THIS MEDICINE AND TELL YOUR DOCTOR IF: Sandoz B.V. Page 2 Levofloxacine Sandoz 5 mg/ml, oplossing voor infusie RVG 101408 V11 1.3.1.3 Bijsl Llegiu el document complet
Sandoz B.V. Pagina 1 Levofloxacine Sandoz 5 mg/ml, oplossing voor infusie RVG 101408 1311-v11 1.3.1.1. Samenvatting van de Productkenmerken December 2019 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Levofloxacine Sandoz 5 mg/ml, oplossing voor infusie 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution for infusion contains 5 mg of levofloxacin (as hemihydrate). Each vial of 50 ml contains 250 mg of levofloxacin (as hemihydrate). Each vial of 100 ml contains 500 mg of levofloxacine (as hemihydrate). Excipients with known effect: Each vial of 50 ml contains 7.7 mmol (177 mg) sodium. Each vial of 100 ml contains 15.4 mmol (354 mg) sodium. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for infusion. Yellow to greenish yellow clear solution, practically free from particles. pH 4.1-5.1 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS [Nationally completed name] is indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1): Acute pyelonephritis and complicated urinary tract infections (see section 4.4) Chronic bacterial prostatitis Inhalation Anthrax (postexposure prophylaxis and curative treatment) (see section 4.4). _ _ In the below mentioned infections Levofloxacin should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the treatment of these infections. Community-acquired pneumonia Complicated skin and soft tissue infections Sandoz B.V. Pagina 2 Levofloxacine Sandoz 5 mg/ml, oplossing voor infusie RVG 101408 1311-v11 1.3.1.1. Samenvatting van de Productkenmerken December 2019 Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION [Nationally completed name] is administered by SLOW intravenous infusion once or twice daily. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen. Treat Llegiu el document complet